Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholders' Equity (Parenthetical)

v3.20.2
Consolidated Statement of Stockholders' Equity (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Jun. 28, 2020
Jun. 28, 2020
Gross proceeds for exercise of warrants  
Restricted common shares issued, value [1]  
Common shares repurchased [2] $ 64 $ 64
Independent Board of Directors [Member]    
Restricted common shares issued, shares 100,000 100,000
Share-based compensation vesting percentage 20.00% 20.00%
Share-based compensation vesting period 5 years 5 years
Restricted common shares issued, value $ 525 $ 525
Amortized over the vesting period, shares 300,000 300,000
Warrant [Member]    
Gross proceeds for exercise of warrants $ 72 $ 72
Fair market value of warranty liability $ 48 $ 48
[1] 100,000 restricted common shares issued to each of the Independent Board of Directors (Rimmy Malhotra, Dale Lehman, Larry Hagenbuch) on April 30, 2020 with 20% vesting as of each January 1 each year over a five-year period. The value of the shares at issue date is $525,000 for 300,000 shares to be amortized over the vesting period.
[2] Common shares repurchased in the open market between June 11, 2020 and June 26, 2020 for $64 thousand and held in treasury stock using the cost method.